Acute Lung Injury
164
4
4
90
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
30 trials with published results (18%)
Research Maturity
90 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.6%
19 terminated out of 164 trials
82.6%
-4.0% vs benchmark
9%
14 trials in Phase 3/4
33%
30 of 90 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 90 completed trials
Clinical Trials (164)
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
Pressure Opening With Electrical Impedance Tomography
Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress
Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)
NAV-ALI: Neurally Adjusted Ventilatory Assist in Patients Recovering Spontaneous Breathing After Acute Lung Injury
Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
The Impact of Automatic Lung Recruitment Postoperative Pulmonary Complications
Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure
Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage
The Acute Respiratory Intervention StudiEs in Africa (ARISE-AFRICA) Study
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO
ALI (Acute Lung Injury) /ARDS (Acute Respiratory Distress Syndrome) in Oncologic Pediatric Patients
Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy
Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy
Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury
Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study